Remove tag big-pharma
article thumbnail

What is Biogen and can they repair their reputation?

World of DTC Marketing

This drug was never about patients; it was about a company whose ego got too big and needed a savior in the form of a medicine that could bring in hundreds of millions of dollars. Physicians and insurers are rejecting Aduhelm because it should never have been approved in the first place. He has zero credibility with the HCP community.

Drugs 222
article thumbnail

Biogen’s Alzheimer’s drug: What’s the price tag on hope?

World of DTC Marketing

With a lot of money pouring in from MS drugs, their CEO decided that they needed to act like big pharma and moved the company to downtown Cambridge under the guise that it was necessary to get closer to biomedical R&D. If the drug is approved you can bet that it’s going to carry a huge price tag.

Drugs 187
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Preview of Pharma Commercials at Super Bowl 2024: From Touching Down with TUMS to Tackling Menopause

XTalks

The countdown to Super Bowl LVIII 2024 has begun and businesses across a variety of sectors, including pharma, have snapped up some of the most coveted advertising airtime of the year. This year, Astellas will be repping pharma once again at the Super Bowl with a new TV spot for Veozah (fezolinetant).

article thumbnail

3 ways pharma marketers can draw inspiration from digitally-native brands

pharmaphorum

Companies like prescription glasses firm Warby Parker, shoe brand Rothy’s and tele-dentistry’s SmileDirectClub have grown up in today’s digitally native environment and can offer some key pointers for pharma. As part of this, a number of big pharma companies are also racing to develop a safe and effective vaccine for the coronavirus.

Branding 130
article thumbnail

American health is in for a “world of hurt”

World of DTC Marketing

An #NHLBI-funded study put a price tag on American’s bad eating habits: $50 billion a year in health care costs, attributable to cardiometabolic diseases such as heart disease, stroke and type 2 diabetes. If they can’t find comfort outside they will find it in a Big Mac and larger orders of fries.

article thumbnail

Orphan drugs and where to launch them: The keys to Europe’s forgotten territories

Pharmaceutical Technology

Due to the high price tags associated with these speciality medicines, innovators have naturally favoured big markets with high GDP such as the US and EU-5 (Germany, France, Spain, Italy, and the UK). Go-to-market strategies. The choice of where to launch an orphan drug is an important and difficult decision.

Drugs 147
article thumbnail

Patent wars: what’s behind Amgen’s possible win over Sanofi at the US Supreme Court

Pharmaceutical Technology

The patent battle between Amgen and Sanofi over their cholesterol-lowering antibodies has divided big pharma in the past months. Both drugs come with a high price tag. This case has broader implications for pharma as an industry, which explains the interest from other businesses.

Antibody 262